Skip to content

Author

Masamichi Ikawa

We have 4 of 27 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Case report Open access Sep 2026

Microbiological replacement associated with recurrent pneumonia during chemotherapy for Hodgkin lymphoma: a case report

Abstract Background. Persistent or recurrent pneumonia during antimicrobial therapy in patients receiving chemotherapy can be difficult to interpret. It may reflect persistence of the initial pathogen, inadequate antimicrobial exposure, noninfectious mimics, aspiration, superinfection or acquisition of a new respirator...

K. Itoh, Nozomi Otsuki, H. Tsutani et al. · 0 citations
Open access Aug 2026

Body mass index modifies cardiovascular risk across blood pressure categories, particularly among underweight adults with hypertension: a 6.3 million‑person nationwide Japanese cohort study.

It is suggested that higher blood pressure may amplify the adverse prognostic significance of underweight, as well as the association between body mass index category and 10-year risk of major adverse cardiovascular events differed across blood pressure categories.

T. Kawano, Tomohisa Seki, Hiroaki Araie et al. · 1 citation
Case report Open access Sep 2026

Dual Aberrant Splicing Caused by an Apparently Missense CHD7 Variant, c.5273A>G (p.Asp1758Gly), in CHARGE Syndrome.

Findings demonstrate that c.5273A>G functions as a LoF variant through dual aberrant splicing rather than a simple missense substitution, which underscores the importance of RNA-level splicing analysis for the accurate interpretation and classification of CHD7 missense variants.

Takashi Okuno, Tatsuto Shimizu, Aiko Igarashi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.